Fluoro Biotech
Developer of recombinant enzyme production systems and local enzyme supply services focused on decentralising enzyme manufacturing for mRNA vaccine production, diagnostics, and research. The company develops a proprietary protein extraction/production platform to enable higher yields, lower-cost workflows, and regional biomanufacturing capacity in South Africa and other underserved markets.
Industries
Nr. of Employees
small (1-50)
Fluoro Biotech
Stellenbosch, Western Cape, South Africa
Products
Molecular enzymes for IVT and mRNA workflows
Recombinant enzymes intended for in vitro transcription workflows, mRNA vaccine manufacturing, diagnostics, and laboratory research.
HIV-1 gp41 (Ectodomain Subtype B)
Infectious disease antigen for diagnostic applications.
HIV-1 p24 (Subtype C Clone)
Infectious disease antigen for diagnostic applications.
SelfPrep
A patented platform technology designed to make the production of essential molecular enzymes and recombinant proteins simpler, faster, more cost-effective, and more sustainable.
HIV-2 gp36 (Ectodomain)
Infectious disease antigen for diagnostic applications.
Molecular enzymes for IVT and mRNA workflows
Recombinant enzymes intended for in vitro transcription workflows, mRNA vaccine manufacturing, diagnostics, and laboratory research.
HIV-1 gp41 (Ectodomain Subtype B)
Infectious disease antigen for diagnostic applications.
HIV-1 p24 (Subtype C Clone)
Infectious disease antigen for diagnostic applications.
SelfPrep
A patented platform technology designed to make the production of essential molecular enzymes and recombinant proteins simpler, faster, more cost-effective, and more sustainable.
HIV-2 gp36 (Ectodomain)
Infectious disease antigen for diagnostic applications.
Services
Custom production and supply of molecular enzymes for research, diagnostics and manufacturing workflows delivered from regional facilities.
Licensing of production systems and transfer support to qualified manufacturers to enable decentralised enzyme production.
Participation in training, programmatic partnerships, and international initiatives to build local mRNA-related manufacturing capacity.
Custom production and supply of molecular enzymes for research, diagnostics and manufacturing workflows delivered from regional facilities.
Licensing of production systems and transfer support to qualified manufacturers to enable decentralised enzyme production.
Participation in training, programmatic partnerships, and international initiatives to build local mRNA-related manufacturing capacity.
Expertise Areas
- Recombinant enzyme manufacturing
- Bioprocess scale-up
- Upstream and downstream bioprocessing
- In vitro transcription (IVT) enzyme production
Key Technologies
- Recombinant protein expression
- Protein extraction and purification
- In vitro transcription (IVT) enzymes
- Enzyme formulation
News & Updates
Profile piece highlighting company and co-founders.
Announcement of chief quality officer completing certified medical devices lead auditor training.
Company participation in national science events in South Africa.
Company CEO invited to speak on scaling biotech in Africa and lessons from building the company.
Presentation of local enzyme production work and partnership with an academic biofoundry to support mRNA value chain readiness.
Announced €350,000 grant (with Stellenbosch University Biofoundry) to expand local production and QC automation for mRNA vaccine enzymes.
Profile piece highlighting company and co-founders.
Announcement of chief quality officer completing certified medical devices lead auditor training.
Company participation in national science events in South Africa.
Company CEO invited to speak on scaling biotech in Africa and lessons from building the company.
Presentation of local enzyme production work and partnership with an academic biofoundry to support mRNA value chain readiness.
Announced €350,000 grant (with Stellenbosch University Biofoundry) to expand local production and QC automation for mRNA vaccine enzymes.